跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DABIGATRAN ETEXILATO SANDOZ 75 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
DABIGATRAN ETEXILATO SANDOZ 75 MG CAPSULAS DURAS EFG
Approved
STANDARD
DABIGATRAN ETEXILATO SANDOZ 75 MG CAPSULAS DURAS EFG
Sandoz Farmaceutica S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 26, 2023
Approval ID
f81e6a7baf265fdf
Company
Sandoz Farmaceutica S.A.
Type
Standard
Approval Details
Approval Id
f81e6a7baf265fdf
Drug Cima Aemps Name
DABIGATRAN ETEXILATO SANDOZ 75 MG CAPSULAS DURAS EFG
Register Number
89059
Holder Company Name
Sandoz Farmaceutica S.A.
Marketing Company Name
Sandoz Farmaceutica S.A.
Authorization Date
2023-09-26
Dosage Form
CÁPSULA DURA
Dose
75 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Sandoz Farmaceutica S.A.
Active Ingredients
DABIGATRAN ETEXILATO
75 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 26, 2023
Approval ID
f81e6a7baf265fdf
Type
Standard
Back to CIMA-AEMPS Approvals
